Home > Boards > US Listed > Medical - Drugs > DelMar Pharmaceuticals, Inc. (DMPI)

Considering this was at 0.4, it has long

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
FallColors Member Profile
 
Followed By 570
Posts 33,944
Boards Moderated 1
Alias Born 01/06/14
160x600 placeholder
DelMar Pharmaceuticals [Nasdaq:DMPI] Enrolls Final Patient in Phase 2 Clinical Trial of VAL-083 For First-Line Treatment of B... PR Newswire (US) - 2/19/2020 8:00:00 AM
DelMar Pharmaceuticals Announces Fiscal Second Quarter 2020 Financial Results and Recent Corporate Updates PR Newswire (US) - 2/13/2020 8:00:00 AM
DelMar Pharmaceuticals to Attend the 22nd Annual BIO CEO & Investor Conference in New York City February 10 and 11, 2020 PR Newswire (US) - 2/5/2020 8:00:00 AM
DelMar Pharmaceuticals Announces Peer-Reviewed Publication of Interim Results of Phase 2 Clinical Trial of VAL-083 As First-L... PR Newswire (US) - 1/29/2020 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/23/2020 3:11:29 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/21/2020 12:18:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/7/2020 8:01:11 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/2/2020 4:21:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/2/2020 4:18:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/2/2020 4:15:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/2/2020 4:13:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/2/2020 4:10:55 PM
DelMar Pharmaceuticals to Present at the LD Micro 12th Annual Main Event on December 10, 2019 PR Newswire (US) - 12/3/2019 8:30:00 AM
/C O R R E C T I O N -- DelMar Pharmaceuticals, Inc./ PR Newswire (US) - 11/25/2019 12:17:00 PM
DelMar Pharmaceuticals Presents Positive Interim Data of VAL-083 Demonstrating Favorable Outcomes In Both Recurrent and Newly... PR Newswire (US) - 11/25/2019 9:51:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/22/2019 6:04:18 AM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 11/21/2019 6:06:01 AM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 11/21/2019 6:04:13 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 11/21/2019 6:01:19 AM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 11/15/2019 4:40:35 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 11/15/2019 4:38:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/14/2019 4:22:03 PM
DelMar Pharmaceuticals Announces Fiscal First Quarter 2020 Financial Results and Recent Corporate Updates PR Newswire (US) - 11/14/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/13/2019 4:57:29 PM
FallColors   Tuesday, 11/26/19 10:37:14 AM
Re: None
Post # of 568 
Considering this was at 0.4, it has long way to fall, the data is not good and market has given thumbs down
Looks like they ran pump from 0.4 to 1.25 and then shorted the crap out..
This will head back to 0.4 where it was and may be even lower with no data points for many months
Ugly dumping..
Damn these biotechs..such a fast pump n dump
Ugly


Those who look for HOME RUN in pennyland eventually BECOME HOMELESS
Be Careful out there
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist